Suppr超能文献

在医院患者中适当使用 D-二聚体。

Appropriate use of D-dimer in hospital patients.

机构信息

Department of Haematology, University of Liverpool, UK.

出版信息

Am J Med. 2010 Jan;123(1):17-9. doi: 10.1016/j.amjmed.2009.09.011.

Abstract

D-dimer, the final product of plasmin-mediated degradation of fibrin-rich thrombi, has emerged as a simple blood test that can be used in diagnostic algorithms for the exclusion of venous thromboembolism. D-dimer also is used as a part of the diagnostic tests for disseminated intravascular coagulation, where excessive thrombin generation is the key pathophysiological factor. However, there are no robust data available at present on the use of this test to exclude venous thromboembolism in a hospital inpatient. Considerable confusion also exists among physicians about its appropriate use and interpretation in disseminated intravascular coagulation. This article focuses on the available evidence to guide the appropriate use of D-dimer in patients admitted to a hospital.

摘要

D-二聚体是纤溶酶介导的纤维蛋白丰富的血栓降解的终产物,已成为一种简单的血液检测方法,可用于排除静脉血栓栓塞症的诊断算法中。D-二聚体也用于弥漫性血管内凝血的诊断测试的一部分,其中过度的凝血酶生成是关键的病理生理因素。然而,目前尚无关于该检测方法在医院住院患者中排除静脉血栓栓塞症的可靠数据。医生们对其在弥漫性血管内凝血中的适当使用和解释也存在相当大的困惑。本文重点介绍了现有证据,以指导在住院患者中使用 D-二聚体的适当方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验